Nano Nuclear Beats Q4 Estimates, Raises $379M to Advance Reactor Licensing
Nano Nuclear posted a Q4 loss of $0.13 per share, beating the $0.29-per-share consensus, and expects $65 million in cash expenditures over the next 12 months. Q1-end cash surged to $577.5 million following a $379 million private placement as the company advances KRONOS MMR licensing and prototype efforts in the US and Canada.
1. Q4 Financial Results
Nano Nuclear reported a fourth-quarter loss of $0.13 per share, outperforming the consensus of $0.29 per share. Management projects approximately $65 million in cash expenditures over the next 12 months to fund operations and development initiatives.
2. Strong Cash Position After Funding
As of December 31, 2025, cash and equivalents rose to $577.5 million from $203.3 million at the prior quarter-end. This increase followed a $379 million net private placement in October 2025, while operating activities used $4.0 million and investing activities used $3.1 million during the quarter.
3. KRONOS MMR Licensing and Commercial Pipeline
Nano Nuclear advanced its KRONOS MMR system toward formal licensing and prototype construction in the US and Canada, including site characterization at the University of Illinois and a related MOU. The company secured a $6.8 million state incentive, acquired Canadian licensing rights via Global First Power, and is in talks with supply chain and commercial partners such as BaRupOn for up to 1 GW of AI data center power.